Geneva, Switzerland, May 26, 2021 – Abologix has been named one of the winners of the Venture Kick stage III start up competition. This award is the pinnacle of the Venture Kick competition. The company will receive 150 000 CHF from Venture Kick in the form of a convertible loan.
top of page
Geneva, Switzerland, November 1, 2020 – Abologix has been named one of the winners of the Venture Kick stage II start up competition.
Geneva, Switzerland, Juy 24, 2020 – The joint project will allow the company to further characterize the effect of blocking JAM-C (Junction Adhesion Molecule C) in hematological malignancies. The project, to be conducted in collaboration with the Geneva University Hospitals (HUG), will receive over 500,000 CHF in the form of a grant.
bottom of page